XML 114 R100.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Share-based compensation      
Total compensation expense $ 3,975 $ 9,647 $ 9,439
Income tax benefits $ 1,143 2,404 2,732
Performance share units      
Share-based compensation      
Stock options vesting period 3 years    
Total compensation expense $ 2,320 6,263 6,860
Expense $ 3,585    
Weighted average period (years) 1 year 4 months 24 days    
Cash payment in settlement of Performance Share Unit Plan Units $ 6,375 $ 6  
Status of, and changes in, the Performance Share Unit Plan units granted to employees      
Outstanding at the beginning of the period (in shares) 521,295    
Granted (in shares) 204,864    
Forfeited (in shares) (55,316)    
Exercised (in shares) (230,754)    
Outstanding at the end of the period (in shares) 440,089 521,295  
Vested and expected to vest (in shares) 440,089    
Lifeco      
Share-based compensation      
Number of trading days considered for determination of average closing price of common stock 20 days    
Lifeco | Option      
Share-based compensation      
Period preceding the date of the grant, to determine exercise price of options granted 5 days    
Options exercisable, term 10 years    
Maximum period that retiring option holders can continue to exercise outstanding options 5 years    
Total compensation expense $ 1,655 $ 3,384 $ 2,579
Expense $ 2,238    
Weighted average period (years) 1 year 8 months 12 days    
Granted (in shares) 714,101    
Compensation expense to be recognized $ 2,376    
Shares under option      
Outstanding at the beginning of the period (in shares) 3,793,658    
Granted (in shares) 714,101    
Exercised (in shares) (692,756)    
Cancelled and Expired (in shares) (181,660)    
Outstanding at the end of the period (in shares) 3,633,343 3,793,658  
Vested and expected to vest at the end of the period (in shares) 3,633,343    
Exercisable at the end of the period (in shares) 2,360,613    
Exercise price (Whole dollars)      
Outstanding at the beginning of the period (in dollars per share) $ 26.49    
Granted (in dollars per share) 25.74    
Exercised (in dollars per share) 20.39    
Cancelled and Expired (in dollars per share) 21.95    
Outstanding at the end of the period (in dollars per share) 21.68 $ 26.49  
Vested and expected to vest at the end of the period (in dollars per share) 21.68    
Exercisable at the end of the period (in dollars per share) $ 21.01    
Remaining contractual term      
Outstanding, December 31, 2015 5 years 10 months 24 days    
Vested and expected to vest, December 31, 2015 5 years 10 months 24 days    
Exercisable, December 31, 2015 4 years 8 months 12 days    
Aggregate intrinsic value      
Outstanding, December 31, 2015 [1] $ 13,154    
Vested and expected to vest, December 31, 2015 [1] 13,154    
Exercisable, December 31, 2015 [1] $ 10,078    
Other information      
Weighted average fair value of options granted (in dollars per share) $ 3.33 $ 5.53 $ 4.56
Intrinsic value of options exercised [2] $ 4,234 $ 401 $ 1,437
Fair value of options vested $ 1,670 $ 4,491 $ 1,843
Weighted-average assumptions      
Dividend yield 3.66% 3.95% 4.53%
Expected volatility 19.10% 26.63% 26.73%
Risk free interest rate 0.90% 1.75% 1.38%
Expected duration (years) 6 years 6 years 6 years
Lifeco | Performance share units      
Share-based compensation      
Number of shares considered for valuation of each stock award 1    
[1] The aggregate intrinsic value is calculated as the difference between the market price of Lifeco common shares on December 31, 2015, and the exercise price of the option (only if the result is positive) multiplied by the number of options.
[2] The intrinsic value of options exercised is calculated as the difference between the market price of Lifeco common shares on the date of exercise and the exercise price of the option multiplied by the number of options exercised.